- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02217995
Mindfulness-Based Cognitive Therapy in a Clinical Sample of OCD Patients
September 4, 2018 updated by: Dr. Neil Rector, Sunnybrook Health Sciences Centre
A Pilot Randomized Trial Testing Mindfulness-Based Cognitive Therapy in a Clinical Sample of OCD Patients
Obsessive Compulsive Disorder (OCD) is a chronic and debilitating disorder known to have reported lifetime prevalence in the range of 2%.
OCD is most commonly treated with Cognitive Behavioural Therapy (CBT) and/or pharmacotherapy.
However, some studies suggest challenges with CBT in retaining gains long term, and while 60-80% of OCD patients respond to SRI treatment, partial symptom reduction is substantial.
Investigations into the effectiveness of alternative, cost-effective treatment modalities are thus needed.
Mindfulness, defined as paying attention in a particular way (on purpose, in the present moment and nonjudgmentally), promotes awareness and attention to internal experience and has been shown to reduce symptoms of anxiety and depression.
A number of controlled studies have found Mindfulness-Based Cognitive Therapy (MBCT) to be effective for depression, social anxiety disorder, and generalized anxiety disorder, but few have tested its effect on obsessive compulsive disorder (OCD).
Moreover, those studies examining MBCT in OCD focused on clinical case studies and non-clinical samples.
This study proposes to examine the effect of MBCT in clinical practice, in a randomized sample of patients with OCD whom are on a clinic wait list.
As patients are allocated to the wait list, they will be randomly assigned to receive either 10 weeks of group MBCT or wait list as per usual.
It is hypothesized that subjects randomly assigned to the MBCT treatment group, compared to those in the wait list control group, will see greater reductions in self-reported measures of OCD symptom severity and improvement in other measures of mindfulness, mood and level of functioning.
The results of this pilot study, if successful, will provide evidence towards another route by which patients can improve their OCD while waiting for clinic services or consultation.
Results will also lend more evidence as to whether MBCT is effective as a stand-alone treatment for clinical OCD, which will inform further investigations into the potential addition of mindfulness techniques to standard care.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M4N 3M5
- The Frederick W. Thompson Anxiety Disorders Centre, Sunnybrook Health Sciences Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Referred for treatment services at the Frederick W. Thompson Anxiety Disorder Centre at Sunnybrook Health Sciences Centre
- Primary Diagnosis of OCD
- Ability to communicate in written and spoken English
Exclusion Criteria:
- Those with active substance abuse/dependence within 3 months
- Suspected organic pathology
- Recent suicide attempt/active suicidality
- Current self-injurious behaviour
- Active bipolar or psychotic disorder
- Previous completion of an MBCT course (≥ 8 weeks)
- Previous completion of an OCD-specific course of CBT (≥ 8 weeks)
- Previous completion of a general course of CBT (≥ 8 weeks) in the past 3 years
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mindfulness-Based Cognitive Therapy (MBCT)
MBCT will be delivered in ten 2.5 hour group sessions with 15 participants per group.
|
MBCT teaches patients to become more aware of, and to relate differently to, their thoughts, feelings, and bodily sensations.
Through MBCT, patients will learn skills that allow them to disengage from habitual ("automatic") dysfunctional cognitive routines, such as obsessional thinking.
As an example, patients are encouraged to relate to thoughts and feelings as passing events in the mind, rather than to identify with them or treat them as accurate representations of reality.
The MBCT protocol for OCD patients is adapted from Segal et al.'s original MBCT manual for depression (Segal, Williams & Teasdale, 2002).
|
|
No Intervention: Waitlist
Wait list as per usual.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Symptom Severity from Baseline in OCD Measures
Time Frame: 10 weeks
|
OCD measures will include: a self-report version of the Yale-Brown Obsessive Compulsive Scale (YBOCS-SR), the Obsessive Compulsive Inventory -Revised (OCI-R), consisting of six subscales (Washing, Checking, Ordering, Obsessing, Hoarding and Neutralising), and the Obsessive Beliefs Questionnaire-44 (OBQ-44), a measure of three OCD-related belief domains (Perfectionism/Certainty, Importance/Control of thoughts, and Responsibility/Threat estimation)
|
10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Level of Impairment from Baseline
Time Frame: 10 weeks
|
The Sheehan Disability Scale will be used to measure level of functional impairment in three inter-related domains (work/school, social and family life).
|
10 weeks
|
|
Change in Mood from Baseline
Time Frame: 10 weeks
|
The Beck Depression Inventory -II (BDI-II), will be used to assess depression severity.
|
10 weeks
|
|
Change in Mindfulness from Baseline
Time Frame: 10 weeks
|
Mindfulness measures include: The Five Facet Mindfulness Questionnaire (FFMQ), used to measure the five constructs central to mindfulness (Observing, Describing, Acting with Awareness, Non-judgment of Inner Experience, and Non-reactivity to Inner Experience), and the the Self-Compassion Scale-Short Form (SCS-SF) measuring 6 components of self-compassion (Self-Kindness, Self-Judgment, Common Humanity, Isolation, Mindfulness & Over-Identification).
|
10 weeks
|
|
Retention of Gains at Follow-up
Time Frame: 16 weeks
|
All self-report measures will be re-administered at 6-week follow-up to measure robustness of gains post-treatment.
|
16 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2014
Primary Completion (Actual)
August 1, 2017
Study Completion (Actual)
September 28, 2017
Study Registration Dates
First Submitted
August 13, 2014
First Submitted That Met QC Criteria
August 13, 2014
First Posted (Estimate)
August 15, 2014
Study Record Updates
Last Update Posted (Actual)
September 6, 2018
Last Update Submitted That Met QC Criteria
September 4, 2018
Last Verified
September 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 138-2014
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obsessive-Compulsive Disorder
-
Shanghai Pudong New Area Mental Health Center,...RecruitingObsessive Compulsive Disorder (OCD) | Obsessive - Compulsive DisorderChina
-
National Institute of Mental Health, Czech RepublicRecruitingObsessive-compulsive DisorderCzechia
-
ASST Fatebenefratelli SaccoFondazione IRCCS San Gerardo dei Tintori; Istittuo ricerca carattere Sceintifico...Enrolling by invitationObsessive - Compulsive DisorderItaly
-
Assiut UniversityNot yet recruitingSubstance Use | Substance Abuse Disorder | Obsessive Compulsive Disorder (OCD) | Obsessive Compulsive Behavior | Obsessive - Compulsive Disorder
-
Shanghai Mental Health CenterNot yet recruitingObsessive - Compulsive DisorderChina
-
Adam FrankRecruitingObsessive - Compulsive DisorderUnited States
-
Anne Katrine PagsbergCopenhagen Trial Unit, Center for Clinical Intervention Research; Danish Research...Active, not recruitingObsessive-Compulsive Disorder in Children | Obsessive-Compulsive Disorder in AdolescenceDenmark
-
Mehmet Emrah KaradereGoztepe Prof Dr Suleyman Yalcın City HospitalRecruitingOCD | Obsessive - Compulsive DisorderTurkey (Türkiye)
-
Taipei Veterans General Hospital, TaiwanRecruitingObsessive-Compulsive Disorder (OCD)Taiwan
-
VU University of AmsterdamUniversity of Bern; Stockholm University; Thomas More University of Applied SciencesNot yet recruitingObsessive Compulsive Disorder (OCD)Sweden, Belgium, Netherlands, Switzerland
Clinical Trials on Mindfulness-Based Cognitive Therapy (MBCT)
-
University Medical Center GroningenUniversity of GroningenCompleted
-
Vanderbilt University Medical CenterCompleted
-
Radboud University Medical CenterFonds Psychische GezondheidCompleted
-
University of California, San FranciscoMount Zion Health FundCompletedDepression | Parkinson Disease | AnxietyUnited States
-
University of AberdeenNHS Greater Glasgow and Clyde; NHS Grampian; University of GlasgowCompletedDepression | Diabetes | AnxietyUnited Kingdom
-
The University of Hong KongThe Hong Kong Jockey Club Charities Trust; Caritas Medical Centre, Hong Kong; The Salvation Army, Hong Kong and Macau Command and other collaboratorsCompleted
-
Guy's and St Thomas' NHS Foundation TrustCompletedVisual Snow Syndrome | Photophobia | Trailing Phenomenon | Visual AuraUnited Kingdom
-
Universidad de los Andes, ChileMinisterio de Educación, ChileActive, not recruitingAnxiety Disorders | Stress, Psychological | Depression, UnipolarChile
-
Chinese University of Hong KongCompleted
-
University of CalgaryAlberta Centre for Child, Family & Community Research; Alberta Family Wellness...CompletedDepression | Stress | AnxietyCanada